Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines by Employing Polymer-Supported Reagents: Preparation of DC-81

Abstract

Polymer-supported reagents have been utilized for the generation of combinatorial library of substituted pyrrolo[2,1-c][1,4]benzodiazepine derivatives that provides a clean and efficient preparation and does not require conventional purification techniques like chromatography. This methodology involves intra molecular aza-Wittig reaction and has been extended for the synthesis of the natural product DC-81 in good overall yields.

polymer-supported reagents - combinatorial library - pyrrolo[2,1-c][1,4] benzodiazepines

References

1a Ley SV. Baxendale IR. Bream RN. Jackson PS. Leach AG. Longbottom DA. Nesi M. Scott JS. Storer RI. Taylor SG. J. Chem. Soc., Perkin Trans. 1  2000,  3815 

1b Ley SV. Baxendale IR. Brusotti G. Caldarelli M. Massi A. Nesi M. Il Farmaco  2002,  57:  321 

1c Baxendale IR. Ley SV. Piutti C. Angew. Chem. Int. Ed.  2002,  41:  2194 

1d Baxendale IR. Lee A.-L. Ley SV. Synlett  2001,  9:  1482 

1e Caldarelli M. Habermann J. Ley SV. J. Chem. Soc., Perkin Trans. 1  1999,  107 

2 Thurston DE. In Molecular Aspects of Anticancer Drug-DNA Interactions   Neidle S. Waring MJ. Macmillan; London: 1993.  p.54 

3 Petrusek RL. Uhlenhopp EL. Duteau N. Hurley LH. J. Biol. Chem.  1982,  257:  6207 

4a Thurston DE. Bose DS. Chem. Rev.  1994,  94:  433 

4b Kamal A. Rao MV. Laxman N. Ramesh G. Reddy GSK. Curr. Med. Chem.: Anti-Cancer Agents  2002,  2:  215 

5a Gregson SJ. Howard PW. Hartley JA. Brooks AA. Adams LJ. Jenkins TC. Kelland LR. Thurston DE. J. Med. Chem.  2001,  44:  737 

5b Gregson SJ. Howard PW. Gullick DR. Hamaguchi A. Corcoran KE. Brooks NA. Hartley JA. Jenkins TC. Patel S. Guille MJ. Thruston DE. J. Med Chem.  2004,  47:  1161 

6a Kamal A. Ramesh G. Ramulu P. Srinivas O. Rehana T. Sheelu G. Bioorg. Med. Chem. Lett.  2003,  13:  3451 

6b Kamal A. Ramulu P. Srinivas O. Ramesh G. Bioorg. Med. Chem. Lett.  2003,  13:  3517 

6c Kamal A. Srinivas O. Ramulu P. Ramesh G. Kumar PP. Bioorg. Med. Chem. Lett.  2003,  13:  3577 

6d Kamal A. Ramesh G. Srinivas O. Ramulu P. Bioorg. Med. Chem. Lett.  2004,  14:  471 

6e Kamal A. Reddy PSMM. Reddy DR. Bioorg. Med. Chem. Lett.  2004,  14:  2669 

6f Kamal A. Reddy KL. Reddy GSK. Reddy BSN. Tetrahedron Lett.  2004,  45:  3499 

7a Kamal A. Reddy PSMM. Reddy DR. Tetrahedron Lett.  2002,  43:  6629 

7b Kamal A. Laxman E. Reddy PSMM. Tetrahedron Lett.  2000,  41:  8631 

7c Kamal A. Laxman E. Arifuddin M. Tetrahedron Lett.  2000,  41:  7743 

7d Kamal A. Laxman E. Reddy PSMM. Synlett  2000,  1476 

8a Kamal A. Reddy GSK. Raghavan S. Bioorg. Med. Chem. Lett.  2001,  11:  387 

8b Kamal A. Reddy GSK. Reddy KL. Tetrahedron Lett.  2001,  42:  6969 

8c Kamal A. Reddy GSK. Reddy KL. Raghavan S. Tetrahedron Lett.  2002,  43:  2103 

8d Kamal A. Reddy KL. Devaiah V. Reddy GSK. Tetrahedron Lett.  2003,  44:  4741 

8e Kamal A. Reddy KL. Devaiah V. Shankaraiah N. Synlett  2004,  1841 

8f Kamal A. Reddy KL. Devaiah V. Shankaraiah N. Reddy YN. Tetrahedron Lett.  2004,  45:  7667 

9a Thurston DE. Bose DS. Chem. Rev.  1994,  94:  433 

9b Kamal A. Howard PW. Reddy BSN. Reddy BSP. Thurston DE. Tetrahedron  1997,  53:  3223 

9c Kamal A. Rao MV. Reddy BSN. Khim. Getero. Soed. (Chem. Heterocycl. Compd.)  1998,  1588 

10a Hu W.-P. Wang J.-J. Lin F.-L. Lin Y.-C. Lin S.-R. Hsu M.-H. J. Org. Chem.  2001,  66:  2881 

10b Mori M. Uozumi Y. Kimura M. Ban Y. Tetrahedron  1986,  42:  3793 

11a Carbateas PM. inventors; US Patent,  3,732,212.  ; Chem. Abstr. 1973, 79, P42570x

11b Carbateas PM. inventors; US Patent,  3,763,183.  ; Chem. Abstr. 1973, 79, P146567t

11c Carbateas PM. inventors; US Patent,  3860600.  ; Chem. Abstr. 1975, 83, P58892x

12a Joshi DD. Sagar AD. Hilage NP. Salunkhe MM. Ind. J. Chem., Sect. B  1993,  32:  1201 

12b Weinshenker NM. Shen CM. Wong JY. Org. Synth., Coll. Vol. VI  1988,  951 

12c Wolman Y. Kivity S. Frankel M. J. Chem. Soc., Chem. Commun.  1967,  629 

12d Liu Y. Vederas JC. J. Org. Chem.  1996,  61:  7856 

12e Grieder A. Thomas AW. Synthesis  2003,  1707 

12f Hinzen B. Ley SV. J. Chem. Soc., Perkin Trans. 1  1997,  1907 

12g Petrini M. Ballini R. Marcantoni E. Rosini G. Synth. Commun.  1988,  18:  847 

13

Preparation of Compound 5g: N-Cyclohexylcarbodiimide, N′-methyl polystyrene (0.66 mmol, 1.30 mmol/g) was added to a dry reaction vessel. The 2-azido-4-benzoxy-5-methoxy benzoic acid (4g, 150 mg, 0.50 mmol) in CH₂Cl₂ (5 mL) was added to the dry resin and the resulting mixture was stirred at r.t. After 5 min, prolinol (34 mg, 0.33 mmol) in CH₂Cl₂ (2 mL) was added and the stirring continued at r.t. for 12 h. The resin was removed by filtration and washed with CH₂Cl₂. Evaporation of the filtrate provided 5g in 98% yield. ¹H NMR (200 MHz, CDCl₃): δ = 1.65-1.90 (3 H, m), 2.15-2.20 (1 H, m), 3.25-3.36 (2 H, m), 3.69-3.86 (2 H, m), 3.84 (3 H, s), 4.28-4.37 (1 H, m), 4.75 (1 H, br s), 5.18 (2 H, s), 6.67 (1 H, s), 6.83 (1 H, s), 7.28-7.46 (5 H, m). MS (EI): m/z = 382 [M⁺].

14

Preparation of Compound 6g: 6-(Methylsulfinyl)hexa-noyl methyl polystyrene (0.52 mmol, 2.20 mmol/g) was swollen in CH₂Cl₂ (5 mL) at r.t. for 15 min and then cooled to -50 °C. Oxalyl chloride (0.52 mmol, 66 mg) in CH₂Cl₂
(1 mL) was added dropwise. After 1 h at that temperature, azido alcohol (5g, 100 mg, 0.26 mmol) in CH₂Cl₂ (1 mL) was added, and the mixture was stirred for 3 h before the addition of Et₃N (0.78 mmol, 79 mg). The mixture was allowed to warm to r.t. and stirred overnight. The resin was removed by filtration and washed with CH₂Cl₂. The filtrate was washed three times with H₂O. The organic phases was dried (Na₂SO₄) and evaporated to afford 6g in 95% yield. ¹H NMR (200 MHz, CDCl₃): δ = 2.14-2.24 (2 H, m), 3.35-3.49 (2 H, m), 3.89 (3 H, s), 4.09-4.15 (2 H, m), 4.60-4.65 (1 H, m), 5.14-5.20 (2 H, m), 6.69 (1 H, s), 7.32-7.47 (6 H, m), 9.69 (1 H, d, J = 2.33 Hz). MS (EI): m/z = 380 [M⁺].

15

Preparation of Compound 7g: Triphenylphosphine polystyrene (0.9 mmol, 3 mmol/g) was suspended in anhyd CH₂Cl₂ (10 mL) and the azido aldehyde (6g, 70 mg, 0.18 mmol) was added, the suspension was stirred for 4 h at r.t. The resin was removed by filtration and washed with CH₂Cl₂. Evaporation of the filtrate to afford 6g in 96% yield. ¹H NMR (400 MHz, CDCl₃): δ = 2.09-2.26 (2 H, m), 3.38-3.80 (5 H, m), 3.87 (3 H, s), 4.98-5.15 (2 H, m), 6.74 (1 H, s), 7.08-7.42 (6 H, m), 7.50 (1 H, d, J = 2.97 Hz). MS (EI): m/z = 336 [M⁺].

16

Preparation of Compound 8: To a solution of compound 7g (50 mg, 0.15 mmol) in absolute EtOH (3 mL) was added 10% Pd/C (75 mg) under nitrogen atmosphere. 1,4-Cyclo-hexadiene (120 mg, 1.50 mmol) was added drop wise to the solution. The resulting solution was stirred at r.t. for 2.5 h. The reaction mixture was filtered and evaporated to afford 8 in 91% yield. ¹H NMR (400 MHz, CDCl₃): δ = 2.01-2.10
(2 H, m), 2.30-2.36 (2 H, m), 3.55-3.61 (1 H, m), 3.70-3.74 (1 H, m), 3.79-3.87 (1 H, m), 3.96 (3 H, s), 6.41 (-OH, br s), 6.90 (1 H, s), 7.52 (1 H, s), 7.67 (1 H, d, J = 4.4 Hz). MS (EI): m/z = 246 [M⁺]. [α]²⁶ _D +296 (c 0.02, CHCl₃); lit. [18] [α]²² _D +135 (c 0.2, CHCl₃).

17 Thurston DE. Murty VS. Langley DR. Jones GB. Synthesis  1990,  81 

18 inventors; Japanese Patent  58180487. Kyowa Hakko Kogyo, Ltd.;